Exceptional response to alpelisib in a heavily pretreated patient with metastatic breast cancer carrying a PIK3CA mutation outside SOLAR-1 eligible mutations: a case report.

Piqray (alpelisib) - Novartis

http://www.ncbi.nlm.nih.gov/pubmed/42775824

Annabelle Forsmark; Christoffer Vannas; Henrik Fagman; Karolina F Larsson; Maja Drakenberg Danese; Maria Kaire; Matilda Liljedahl

Sep 24, 2026